Brief: Sprint Bioscience Q2 operating profit falls to SEK 1.0 mln
Aug 23 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* Q2 REVENUE SEK 11.5 MILLION VERSUS SEK 17.8 MILLION YEAR
AGO
* Q2 OPERATING PROFIT SEK 1.0 MILLION VERSUS SEK 4.1
MILLION YEAR AGO
Source text for Eikon: ID:nWkr96VZqG
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln